FAM13A
protein-codingfamily with sequence similarity 13 member A, the group of Rho GTPase activating proteins
Gene summary
Predicted to enable GTPase activator activity. Predicted to be involved in regulation of small GTPase mediated signal transduction. Predicted to be located in cytosol. Implicated in chronic obstructive pulmonary disease. [provided by Alliance of Genome Resources, Jul 2025]
- FAM13A1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~385.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FAM13A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014883.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 3 | 2 | 7 | ||
| missense | 1 | 126 | 5 | 1 | 133 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 1 | 132 | 8 | 3 | 144 |
Highest pathogenic variant AF is 0.000047311874
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055698.2 | 24 | MANE Select | |
| Ensembl | ENSP00000264344.5 | 24 | MANE Select | |
| RefSeq | NP_001015045.1 | 18 | Standard | |
| RefSeq | NP_001252507.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lung fibrosis
- Signal Transduction
- Rho GTPase cycle
- Signaling by Rho GTPases
Biological Process
- signal transduction
- positive regulation of GTPase activity
- regulation of small GTPase mediated signal transduction
Molecular Function
- GTPase activator activity
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000264344
- Coding exons
- 24
- Length
- 385444
- Individuals with no LoFs
- 125132
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 614
- Defined
- 125748
- p
- 0.00245
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.801 | 510 | 563 | 0.905 | 0.0000311 | 6758 |
| Missense (PolyPhen) | 164 | 200.42 | 0.81828 | 2377 | ||
| Synonymous | 1.13 | 190 | 211 | 0.901 | 0.0000117 | 1904 |
| Loss of Function | 2.64 | 38 | 60.1 | 0.633 | 0.00000345 | 683 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0014 | 0.0012 | notable |
| Latino/Admixed American | 0.0024 | 0.0023 | notable |
| Ashkenazi Jewish | 0.0020 | 0.0019 | notable |
| East Asian | 0.00012 | 0.00011 | rare |
| Finnish | 0.014 | 0.014 | notable |
| European (Non-Finnish) | 0.0014 | 0.0013 | notable |
| South Asian | 0.00067 | 0.00062 | rare |
| Other | 0.0034 | 0.0033 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- LoFtool
- 0.987
- RVIS EVS
- -0.37
- RVIS percentile EVS
- 28.26
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.302
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |